THE TIMING OF ANDROGEN ABLATION THERAPY AND OR CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CANCER

被引：146

作者：

ISAACS, JT

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,DEPT UROL,BALTIMORE,MD 21205

[2] JOHNS HOPKINS UNIV HOSP,JAMES BUCHANAN BRADY UROL INST,BALTIMORE,MD 21205

来源：

关键词：

D O I：

10.1002/pros.2990050102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 17

页数：17

共 10 条

[1] BRENDLER H, 1969, J AMER MED ASSOC, V210, P1074
[2] Bruchovsky N, 1975, Vitam Horm, V33, P61
[3] EFFECTS OF CASTRATION AND ANDROGEN REPLACEMENT ON THE NUCLEIC ACID COMPOSITION, METABOLISM, AND ENZYMATIC CAPACITIES OF THE RAT VENTRAL PROSTATE
BUTLER, WWS
SCHADE, AL
[J]. ENDOCRINOLOGY, 1958, 63 (03) : 271 - 279
[4] POLYMERIZATION OF DEOXYRIBONUCLEOTIDES IN RELATION TO ANDROGEN-INDUCED PROSTATIC GROWTH
COFFEY, DS
SHIMAZAKI, J
WILLIAMS.HG
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1968, 124 (1-3) : 184 - +
[5] HAKANSSON L, 1974, ACTA PATH MICRO IM A, VA 82, P35
[6] ISAACS JT, 1981, CANCER RES, V41, P5070
[7] ISAACS JT, 1984, PROSTATE
[8] ISAACS JT, 1982, SCI F UROLOGY, P743
[9] MENON M, 1979, PROSTATIC CANCER, P175
[10] EARLY COMBINED HORMONAL AND CHEMOTHERAPY FOR METASTATIC CARCINOMA OF PROSTATE
MUKAMEL, E
NISSENKORN, I
SERVADIO, C
[J]. UROLOGY, 1980, 16 (03) : 257 - 260